| Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit A Saleem, M Husheem, P Härkönen, K Pihlaja Journal of Ethnopharmacology 81 (3), 327-336, 2002 | 682 | 2002 |
| Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture Q Qu, M Perälä-Heape, A Kapanen, J Dahllund, J Salo, HK Väänänen, ... Bone 22 (3), 201-209, 1998 | 384 | 1998 |
| Estrogen and bone metabolism HK Väänänen, PL Härkönen Maturitas 23, S65-S69, 1996 | 381 | 1996 |
| VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors MMT Mattila, JK Ruohola, T Karpanen, DG Jackson, K Alitalo, ... International journal of cancer 98 (6), 946-951, 2002 | 375 | 2002 |
| Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells JK Ruohola, EM Valve, MJ Karkkainen, V Joukov, K Alitalo, PL Härkönen Molecular and cellular endocrinology 149 (1-2), 29-40, 1999 | 333 | 1999 |
| Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. KS Selander, J Mönkkönen, EK Karhukorpi, P Härkönen, R Hannuniemi, ... Molecular pharmacology 50 (5), 1127-1138, 1996 | 308 | 1996 |
| Carbonic anhydrase III protects cells from hydrogen peroxide‐induced apoptosis SR Räisänen, P Lehenkari, M Tasanen, P Rahkila, PL Härkönen, ... The FASEB Journal 13 (3), 513-522, 1999 | 285 | 1999 |
| Prolactin and prolactin receptors are expressed and functioning in human prostate. PLH MT Nevalainen, EM Valve, PM Ingleton, M Nurmi, PM Martikainen Journal of Clinical Investigation 99, 618-627, 1997 | 259 | 1997 |
| Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption H Michael, PL Härkönen, HK Väänänen, TA Hentunen Journal of Bone and Mineral Research 20 (12), 2224-2232, 2005 | 255 | 2005 |
| Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro AM Wärri, RL Huovinen, AM Laine, PM Martikainen, PL Härkönen JNCI: Journal of the National Cancer Institute 85 (17), 1412-1418, 1993 | 244 | 1993 |
| Role of estrogens in development of prostate cancer PL Härkönen, SI Mäkelä The Journal of steroid biochemistry and molecular biology 92 (4), 297-305, 2004 | 241 | 2004 |
| The in vitro cytotoxic and apoptotic activity of Triphala—an Indian herbal drug S Kaur, H Michael, S Arora, PL Härkönen, S Kumar Journal of ethnopharmacology 97 (1), 15-20, 2005 | 238 | 2005 |
| Cleavable ErbB4 isoform in estrogen receptor–regulated growth of breast cancer cells TT Junttila, M Sundvall, M Lundin, J Lundin, M Tanner, P Härkönen, ... Cancer research 65 (4), 1384-1393, 2005 | 231 | 2005 |
| Expression of glucose transporters in head‐and‐neck tumors P Mellanen, H Minn, R Grenman, P Härkönen International journal of cancer 56 (5), 622-629, 1994 | 219 | 1994 |
| Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway SS Virtanen, HK Väänänen, PL Härkönen, PT Lakkakorpi Cancer research 62 (9), 2708-2714, 2002 | 211 | 2002 |
| Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer P Uotila, E Valve, P Martikainen, M Nevalainen, M Nurmi, P Härkönen Urological research 29, 25-28, 2001 | 207 | 2001 |
| Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells A Kallio, A Zheng, J Dahllund, KM Heiskanen, P Härkönen Apoptosis 10, 1395-1410, 2005 | 177 | 2005 |
| Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen A Zheng, A Kallio, P Harkonen Endocrinology 148 (6), 2764-2777, 2007 | 171 | 2007 |
| Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats Q Qu, H Zheng, J Dahllund, A Laine, N Cockcroft, Z Peng, M Koskinen, ... Endocrinology 141 (2), 809-820, 2000 | 163 | 2000 |
| The Wnt-5a–Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo by Targeting Cell Motility A Safholm, J Tuomela, J Rosenkvist, J Dejmek, P Harkonen, T Andersson Clinical Cancer Research 14 (20), 6556-6563, 2008 | 157 | 2008 |
